Nonproteolytic activation of prorenin by the (pro)renin receptor is blocked by decoy peptide

Inagami T. Purification of renin and prorenin. Hypertension 1991;18:241-51.

Morris BJ Molecular biology of renin. I: Gene and protein structure, synthesis and processing . J Hypertens 1992;10:209-14.

Suzuki F. , Tanaka N. , Takeuchi K. et al. Acid-activation of rat prorenin following non-proteolytic alteration . In: Takahashi, K., (ed.) Aspartic Proteinases. New York: Plenum Publishing Co., 1995:267-72.

Baxter JD , James MN , Chu WN et al. The molecular biology of human renin and its gene. Yale J Biol Med 1989; 62:493-501.

Heinrikson RL , Hui J. , Zurcher-Neely H. et al. A structural model to explain the partial catalytic activity of human prorenin. Am J Hypertens 1989;2:367-80.

Suzuki F. , Nakagawa T. , Kakidachi et al. The dominant role of the prosegment of prorenin in determining the rate of activation by acid or trypsin: studies with molecular chimeras. Biochem Biophys Res Commun 2000; 267:577-80.

Sealey JE , Glorioso N. , Itskovitz J. , Laragh JH Prorenin as a reproductive hormone. New form of the renin system. Am J Med 1986;81:1041-6.

Leckie BJ , Birnie G. , Carachi R. Renin in Wilms' tumor: prorenin as an indicator. J Clin Endocrinol Metab 1994;79:1742-6.

Luetsher JA , Kraemer FB , Wilson DM et al. Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications. N Engl J Med 1985;312: 1412-17.

Naruse M. , Wasada T. , Naruse K. et al. Pathophysiological significance of plasma total renin and prorenin in patients with diabetes mellitus. Endocr J 1995;42:225-33.

Schalekamp MAH. Renin-angiotensin system components and endothelial proteins as markers of diabetic microvascular disease. Clin Investig 1993;71:S3-S6.

Yokota H. , Nagaoka T. , Mori F. et al. Prorenin levels in retinopathy of prematurity. Am J Ophthalmol 2007;143: 531-3.

Ichihara A. , Hayashi M. , Kaneshiro Y. et al. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the `handle` region for nonproteolytic activation of prorenin. J Clin Invest 2004 ;114:1128-35.

Ichihara A. , Kaneshiro Y. , Suzuki F. Prorenin receptor blockers: effects on cardiovascular complications of 2006;15:1137-9. diabetes and hypertension . Expert Opin Investig Drugs

Danser AHJ , Deinum J. Renin, Prorenin and the Putative (Pro)renin Receptor. Hypertension 2005;46:1069-76.

Nguyen G. , Danser AHJ. The (pro)renin receptor: therapeutic consequences. Expert Opin Investig Drugs 2006;15:1131-5.

Nguyen G. , Delarue F. , Burckle et al. Pivotal role of the J renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002;109:1417-27.

Suzuki F. , Hayakawa M. , Nakagawa T. et al. Human prorenin has `Gate and Handle` regions for its nonproteolytic activation. J Biol Chem 2003;278:22217-22.

Schefe JH , Menk M. , Reinemund J. et al. A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ Res 2006;99:1355-66.

Burckle C. , Bader M. Prorenin and Its Ancient Receptor. Hypertension 2006;48:549-51.

Nabi AHM N. , Kageshima A. , Nasir MU et al. Binding properties of rat prorenin and renin to the recombinant rat renin/prorenin receptor prepared by a baculovirus expression system. Int J Mol Med 2006;18:483-8.

Nabi AHM N. , Nasir MU , Nakagawa T. et al. Role of "handle" region of prosegment part of prorenin in "Receptor Associated Prorenin System" . J Hypertens 2005;23:(suppl)S259.